By Amber Murray International veterinary pharmaceutical and services business Animalcare has reported a “transformation” in its balance sheet after two sales worth £27.7m, as well as a boost in revenue. The AIM-listed, York-based company told markets this morning that its revenue rose by five per cent to £36.9m, from £35.2m in the first half of 2023. Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) grew by 2.5 per cent to £6.6m from £6.5m in the same period of 2023. In particular, Animalcare said its Plaqtiv+ dental range and Daxocox osteoarthritis treatment ret…